Search research articles
Contact Us
Filters
Showing results (161-170 of 225) with videos related to
Page
of 23
Sort By:
Coronary Artery Disease
|
December 23, 2016
Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease
Anupama Vasudevan, Teodoro Bottiglieri, Kristen M Tecson, et al.
Journal of Inherited Metabolic Disease
|
August 28, 2015
Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice
Jin-Song Shen, Andreas Busch, Taniqua S Day, et al.
Medicine
|
March 13, 2002
Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course
Mary H Branton, Raphael Schiffmann, Sharda G Sabnis, et al.
Journal of Inherited Metabolic Disease
|
November 8, 2017
Priapism in a Fabry disease mouse model is associated with upregulated penile nNOS and eNOS expression
Xing-Li Meng, Erland Arning, Mary Wight-Carter, et al.
Frontiers in Neurology
|
January 31, 2018
Oculomotor and Vestibular Findings in Gaucher Disease Type 3 and Their Correlation with Neurological Findings
Tatiana Bremova-Ertl, Raphael Schiffmann, Marc C Patterson, et al.
American Journal of Medical Genetics. Part A
|
March 29, 2019
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Gere Sunder-Plassmann, et al.
Neurology. Genetics
|
August 18, 2020
D-DEMØ, a distinct phenotype caused by <i>ATP1A3</i> mutations
Lyndsey Prange, Milton Pratt, Kristin Herman, et al.
Clinical Pharmacology in Drug Development
|
April 20, 2021
Migalastat Tissue Distribution: Extrapolation From Mice to Humans Using Pharmacokinetic Modeling and Comparison With Agalsidase Beta Tissue Distribution in Mice
Yi Shuan Wu, Richie Khanna, Virginia Schmith, et al.
Molecular Genetics and Metabolism
|
November 22, 2016
Roscoe Owen Brady, MD: Remembrances of co-investigators and colleagues
Robert J Desnick, Norman W Barton, Scott Furbish, et al.
Brain : a Journal of Neurology
|
October 18, 2022
Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial
Raphael Schiffmann, Timothy M Cox, Jean-François Dedieu, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 225) with videos related to
Sort By:
Page
of 23
Coronary Artery Disease
|
December 23, 2016
Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease
Anupama Vasudevan, Teodoro Bottiglieri, Kristen M Tecson, et al.
Journal of Inherited Metabolic Disease
|
August 28, 2015
Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice
Jin-Song Shen, Andreas Busch, Taniqua S Day, et al.
Medicine
|
March 13, 2002
Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course
Mary H Branton, Raphael Schiffmann, Sharda G Sabnis, et al.
Journal of Inherited Metabolic Disease
|
November 8, 2017
Priapism in a Fabry disease mouse model is associated with upregulated penile nNOS and eNOS expression
Xing-Li Meng, Erland Arning, Mary Wight-Carter, et al.
Frontiers in Neurology
|
January 31, 2018
Oculomotor and Vestibular Findings in Gaucher Disease Type 3 and Their Correlation with Neurological Findings
Tatiana Bremova-Ertl, Raphael Schiffmann, Marc C Patterson, et al.
American Journal of Medical Genetics. Part A
|
March 29, 2019
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Gere Sunder-Plassmann, et al.
Neurology. Genetics
|
August 18, 2020
D-DEMØ, a distinct phenotype caused by <i>ATP1A3</i> mutations
Lyndsey Prange, Milton Pratt, Kristin Herman, et al.
Clinical Pharmacology in Drug Development
|
April 20, 2021
Migalastat Tissue Distribution: Extrapolation From Mice to Humans Using Pharmacokinetic Modeling and Comparison With Agalsidase Beta Tissue Distribution in Mice
Yi Shuan Wu, Richie Khanna, Virginia Schmith, et al.
Molecular Genetics and Metabolism
|
November 22, 2016
Roscoe Owen Brady, MD: Remembrances of co-investigators and colleagues
Robert J Desnick, Norman W Barton, Scott Furbish, et al.
Brain : a Journal of Neurology
|
October 18, 2022
Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial
Raphael Schiffmann, Timothy M Cox, Jean-François Dedieu, et al.
Page
of 23